( MENAFN - GlobeNewsWire - Nasdaq C )HARLOTTESVILLE, Va., Feb. 18, 2021 (GLOBE NEWSWIRE) Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) ( Diffusion or the Company ), an innovative biopharmaceutical company developing novel therapies to deliver oxygen to areas of the body where it is needed most, announced today that the underwriter of its previously announced underwritten public offering has exercised in full its option to purchase an additional 4,390,244 shares of its common stock at a price to the public of $1.025 per share, less underwriting discounts and commissions. After giving effect to the option closing, the aggregate gross proceeds to Diffusion from the offering were approximately $34.5 million, before deducting underwriting discounts and commissions and offering expenses payable by Diffusion.
Renewables and Industrial Applications Drive Demand
/EIN News/ AYER, Mass., Feb. 18, 2021 (GLOBE NEWSWIRE) AMSC (NASDAQ: AMSC), a leading system provider of megawatt-scale power resiliency solutions that orchestrate the rhythm and harmony of power on the grid™ and protect and expand the capability of our Navy’s fleet, today announced $15 million of new energy power system orders. This includes orders for AMSC’s D-VAR® STATCOM system, AMSC’s D-VAR VVO® system as well as NEPSI’s metal enclosed capacitor banks and harmonic filters. The orders principally serve the renewable and industrial sectors in the United States. These systems are expected to provide voltage regulation by responding to varying load conditions on the electric grid. Most of the revenue from these orders is expected to be recognized in fiscal year 2021.
Pharnext Announces Financing of €11 Million Through a Capital Raise Subscribed by Existing Shareholders and a Convertible Bonds Issued to European Investors
€5 million convertible bonds issued to European investors,
European investors have also provided written indication of strong interest for the potential of additional €25 million in similar convertible bonds, depending on future market conditions
PARIS, FRANCE / ACCESSWIRE / February 4, 2021 / Pharnext SA (FR0011191287 - ALPHA) (the
Company ), an advanced late-stage clinical biopharmaceutical company pioneering new approaches to developing innovative drug combinations based on big genomics data and artificial intelligence using its PLEOTHERAPY platform, today announced a financing of €11 million through the combination of a €6 million capital raise subscribed by two existing shareholders by way of issuance of new ordinary shares (the
Pharnext Announces Financing of EUR11 Million -2- finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
AMSC Reports Third Quarter Fiscal Year 2020 Financial Results and Provides Business Outlook Company to host conference call tomorrow, February 4 at 10:00 am ET
February 03, 2021 16:05 ET | Source: AMSC AMSC Ayer, Massachusetts, UNITED STATES
AYER, Mass., Feb. 03, 2021 (GLOBE NEWSWIRE) AMSC (Nasdaq: AMSC), a leading system provider of megawatt-scale power resiliency solutions that orchestrate the rhythm and harmony of power on the grid™, and protect and expand the capability and resiliency of our Navy’s fleet, today reported financial results for its third quarter of fiscal year 2020 ended December 31, 2020.
Revenues for the third quarter of fiscal 2020 were $23.6 million compared with $17.9 million for the same period of fiscal 2019. The year-over-year increase was a result of higher Grid and Wind segment revenues versus the year ago period. The higher Grid segment revenues were primarily due